Designer ubiquitin ligases for regulation of intracellular pathogenic proteins
AssigneeSynaptic Research, LLC
InventorsGeorge A. Oyler, Yien Che Tsai
Life of this patent
Estimating the term…
Loading patent…
AssigneeSynaptic Research, LLC
InventorsGeorge A. Oyler, Yien Che Tsai
Estimating the term…
The present invention relates to a designer or recombinant ubiquitin ligase molecule that includes a toxin binding domain that is specific for a toxin active fragment, wherein the toxin active fragment is an enzymatically active fragment of one or more toxins or toxin serotypes; and an E3-ligase domain that comprises an E3-ligase or polypeptide that facilitates E2-mediated ubiquitination of the toxin active fragment. In an embodiment, the composition further includes a delivery system that allow the designer ubiquitin ligase to enter the cell. The present invention further includes methods for treating an individual intoxicated with a toxin by administering the designer ubiquitin ligase of the present invention.
A method of degrading or inhibiting one or more botulinum neurotoxin (BoNT) serotypes that have intoxicated one or more cells, wherein the method comprises contacting an amount of an isolated recombinant ubiquitin ligase molecule with the intoxicated cells, wherein the isolated recombinant ubiquitin ligase molecule comprises:
A method of treating an individual having one or more cells intoxicated with one or more BoNT serotypes, wherein the method comprises administering to the individual an amount of an isolated recombinant ubiquitin ligase molecule in a carrier, wherein the isolated recombinant ubiquitin ligase molecule comprises:
An isolated nucleic acid molecule that encodes a recombinant ubiquitin ligase molecule, wherein recombinant ubiquitin ligase comprises:
An isolated nucleic acid molecule that encodes a recombinant ubiquitin ligase molecule, wherein recombinant ubiquitin ligase comprises:
An isolated nucleic acid molecule that encodes a recombinant ubiquitin ligase molecule, wherein the nucleic acid molecule consists essentially of a nucleic acid sequence selected from the group consisting of:
An isolated nucleic acid molecule that encodes a recombinant ubiquitin ligase molecule, wherein recombinant ubiquitin ligase molecule is selected from the group consisting of:
Dependencies are inferred from the claim text.